Application
FAM107A Antibody (N-term) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the FAM107A antibody detected the FAM107A protein (arrow).Application
Western blot analysis of FAM107A (arrow) using rabbit polyclonal FAM107A Antibody (N-term) . 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the FAM107A gene.| Product Name | FAM107A Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | FAM107A; DRR1; TU3A; Protein FAM107A; Down-regulated in renal cell carcinoma 1; Protein TU3A |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | DRR1 TU3A |
|---|---|
| Alternative Names | FAM107A DRR1 TU3A Protein FAM107A Down-regulated in renal cell carcinoma 1 Protein TU3A |
| Molecular Weight(MW) | 17455 Da |
| Function | When transfected into cell lines in which it is not expressed, suppresses cell growth. May play a role in tumor development |
| Tissue Specificity | Widely expressed in normal tissues. Expression is reduced or absent in a number of cancer cell lines |
| Cellular Localization | Nucleus. |
| Entrez Gene | 11170 |
|---|---|
| Nucleotide Accession | NP_009108.1 |
Application
FAM107A Antibody (N-term) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the FAM107A antibody detected the FAM107A protein (arrow).
Application
Western blot analysis of FAM107A (arrow) using rabbit polyclonal FAM107A Antibody (N-term) . 293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected (Lane 2) with the FAM107A gene.| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
